35.47
5.38%
1.81
시간 외 거래:
35.47
전일 마감가:
$33.66
열려 있는:
$33.33
하루 거래량:
1.06M
Relative Volume:
1.76
시가총액:
$1.73B
수익:
$429.95M
순이익/손실:
$-40.12M
주가수익비율:
-65.69
EPS:
-0.54
순현금흐름:
$-19.66M
1주 성능:
+20.52%
1개월 성능:
+28.37%
6개월 성능:
+69.79%
1년 성능:
-4.08%
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
Atricure Inc Stock (ATRC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2020-12-18 | 재확인 | Needham | Buy |
2020-11-06 | 재확인 | Needham | Buy |
2020-04-07 | 개시 | Oppenheimer | Outperform |
2020-02-06 | 개시 | BTIG Research | Buy |
2020-01-24 | 재확인 | Needham | Buy |
2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
2019-04-12 | 개시 | JP Morgan | Overweight |
2018-10-04 | 재확인 | Needham | Buy |
2018-08-02 | 재확인 | Needham | Buy |
2018-08-02 | 재확인 | Stifel | Buy |
2018-06-18 | 재확인 | Needham | Buy |
2018-04-27 | 재확인 | Needham | Buy |
2018-01-16 | 재확인 | Needham | Buy |
2017-11-02 | 재확인 | Needham | Buy |
2017-07-28 | 재확인 | Needham | Buy |
2017-05-30 | 재개 | Piper Jaffray | Overweight |
2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
2015-10-28 | 재확인 | Needham | Buy |
2015-10-06 | 재확인 | Canaccord Genuity | Buy |
2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday - MSN
US$42.67That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results - Simply Wall St
AtriCure, Inc. (NASDAQ:ATRC) Q3 2024 Earnings Call Transcript - Insider Monkey
AtriCure Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? - Simply Wall St
Earnings call: AtriCure reports robust growth, raises full-year guidance By Investing.com - Investing.com Nigeria
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
AtriCure price target raised to $36 from $32 at Oppenheimer - MSN
AtriCure (NASDAQ:ATRC) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation - Investing.com India
AtriCure (NASDAQ:ATRC) Shares Gap Up Following Strong Earnings - MarketBeat
AtriCure (NASDAQ:ATRC) Given New $40.00 Price Target at Needham & Company LLC - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 8.4% in October - MarketBeat
AtriCure Reports Strong Growth in Q3 2024 Earnings - TipRanks
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Yahoo Finance
AtriCure: Q3 Earnings Snapshot - The Washington Post
AtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings Guidance - MarketBeat
AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
AtriCure Inc (ATRC) Q3 2024 Earnings: Revenue Surpasses Estimates at $115.9 Million, Net Loss Per Share at $0.17 - GuruFocus.com
AtriCure Reports Third Quarter 2024 Financial Results - StockTitan
Assenagon Asset Management S.A. Purchases 138,046 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure to Participate in the UBS Global Healthcare Conference - StockTitan
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
AtriCure (ATRC) Scheduled to Post Earnings on Tuesday - MarketBeat
Cardiac Ablation Technology Market Analysis By Top Keyplayers - openPR
(ATRC) Long Term Investment Analysis - Stock Traders Daily
AtriCure Inc (ATRC) Trading Down 2.91% on Oct 17 - GuruFocus.com
SG Americas Securities LLC Buys New Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device - Yahoo Finance
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management - BioSpace
AtriCure launches new CryoSphere Max cryoablation probe - Mass Device
Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago - Yahoo Finance
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe - Yahoo Finance
Atrial Fibrillation Market Rapid Growth, Challenges, - openPR
Atrial Appendage Occluder Market Set to Soar to USD 8,193.0 Million by 2033 at a 23.6% of CAGR - Future Market Insights
Is Atricure Inc (ATRC) a threat to investors? - US Post News
Transcatheter Embolization and Occlusion Devices Market Analysis To 2031 | Inc, AtriCure, Stryker Corporation, Merit Medical System, Pfizer, Inc, Edwards – Times-BD24 - Times-BD24
Where are the Opportunities in (ATRC) - Stock Traders Daily
There is no doubt that Atricure Inc (ATRC) ticks all the boxes. - SETE News
Market Insight: Atricure Inc (ATRC)’s Notable Drop, Closing at 27.07 - The Dwinnex
Atrial Fibrillation Market Growth Analysis with Investment Opportunities For 2024-2033 - EIN News
AtriCure to Announce Third Quarter 2024 Financial Results - StockTitan
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Millennium Management LLC Has $21.69 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure wins CE mark for EnCompass clamp device - Mass Device
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):